Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurocrine Biosciences (NBIX) Asset Utilization Ratio: 2011-2020

Historic Asset Utilization Ratio for Neurocrine Biosciences (NBIX) over the last 9 years, with Dec 2020 value amounting to 0.69.

  • Neurocrine Biosciences' Asset Utilization Ratio fell 22.06% to 0.54 in Q3 2021 from the same period last year, while for Sep 2021 it was 0.54, marking a year-over-year decrease of 22.06%. This contributed to the annual value of 0.69 for FY2020, which is 0.35% up from last year.
  • Neurocrine Biosciences' Asset Utilization Ratio amounted to 0.69 in FY2020, which was up 0.35% from 0.69 recorded in FY2019.
  • Over the past 5 years, Neurocrine Biosciences' Asset Utilization Ratio peaked at 0.69 during FY2020, and registered a low of 0.03 during FY2017.
  • In the last 3 years, Neurocrine Biosciences' Asset Utilization Ratio had a median value of 0.69 in 2019 and averaged 0.62.
  • Its Asset Utilization Ratio has fluctuated over the past 5 years, first slumped by 35.25% in 2016, then surged by 1,864.66% in 2018.
  • Over the past 5 years, Neurocrine Biosciences' Asset Utilization Ratio (Yearly) stood at 0.04 in 2016, then dropped by 28.99% to 0.03 in 2017, then soared by 1,864.66% to 0.50 in 2018, then spiked by 37.56% to 0.69 in 2019, then grew by 0.35% to 0.69 in 2020.